Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Apr/23/2021 82 20
Adjuvanted SARS-CoV-2 Spike protein Potential treatment - pre-clinical evidence Experimental Vaccine Apr/01/2021 4 0
Quercetin Potential treatment - theoretical effect Natural product Antiviral Feb/24/2021 12 0
Peptide #2 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/11/2021 1 0
CR-31-B (-) Potential treatment - pre-clinical evidence Experimental Antiviral Jan/08/2021 1 0
Ellagic acid Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021 2 0
Euscaphic acid Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021 1 0
Theasapogenol B Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021 1 0
Arjunic acid Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021 1 0
Psychotrine Potential treatment - theoretical effect Natural product Antiviral Jan/06/2021 1 0